To address the paucity of tools for directly measuring MET activation in tumor cells within patient biopsy specimens, we developed a robust, quantitative immunofluorescence microscopy assay to measure levels of pY1235MET and total MET in in vitro, in vivo, and patient tumor specimens. Here, MET is linked to neoplasm.